Taizhou, Jiangsu, China Zhejiang Xianju Pharmaceutical appeared to be the Corporate Investor, which was created in 1972. The company was established in Asia in China. The main office of represented Corporate Investor is situated in the Taizhou.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Denovo Biopharma. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The fund was created by Jingde Jin.
The high activity for fund was in 2015. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Guangzhou YUEXIU Industrial Investment Fund, GoldStone Investment. In the next rounds fund is usually obtained by Zheshang Industrial Integration Asset Management, Share Capital, Sangel Capital.
| Fund Name | Location |
| Aegon Industrial Fund Management Co. | - |
| Al Salam Bank-Bahrain | - |
| Ardent Venture Partners | - |
| Aspen Finance Investors | - |
| B-Con LP | - |
| Bonjour Holdings | China, Hong Kong, New Territories |
| Credit Suisse Loan Funding | - |
| GSX | Japan, Tokyo |
| Incubio | Barcelona, Catalonia, Spain |
| Korea Venture Investment Corp | Seoul, Seoul-t'ukpyolsi, South Korea |
| Larsen MacColl Partners | Pennsylvania, Radnor, United States |
| MIT Inclusive Innovation Challenge | Cambridge, Massachusetts, United States |
| Ningo Meishan Baoshui Gangqu Yunwanxingtong Investment Management | China, Ningbo, Zhejiang |
| Pasadena Angels | Altadena, California, United States |
| Relevance Ventures (formerly Relevance Capital) | Brentwood, Tennessee, United States |
| Sands Capital Ventures | Arlington, United States, Virginia |
| Schmidt Family Foundation | - |
| Tsingbay Venture Capital | China, Guangdong, Shenzhen |
| Westar Capital | Australia, Perth, Western Australia |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Denovo Biopharma | 01 Jul 2015 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Denovo Biopharma | 01 Jul 2015 | San Diego, California, United States |
